The bridge between the digital age and diabetes is being built. The Buddi wearable is currently being tested in the U.K. by King’s Health Partners, an academic health science center. The wearable mobile aims to prevent the development of type 2 diabetes.
The tests are taking place in London where 200 patients who are at risk of developing the disease will trial the wearable wrist-band and app combo for one year.
“Current intensive and expensive methods are not sustainable given the projected growth of the disease and we have a duty to develop new solutions to help tackle the problem.”
The patients’ activities will be tracked by the device that will provide patients with encouraging advice that promotes exercise programs tailored to their needs. The app will also monitor food intake with the aim of cutting out foods high in sugar and fat.
Sara Murray, the CEO and founder Buddi explained that in the face of the explosive growth of obesity and type 2 diabetes innovations in clinical services are required.
“Current intensive and expensive methods are not sustainable given the projected growth of the disease and we have a duty to develop new solutions to help tackle the problem.”
If the test trial is a success, the available of the Buddi Wearable will become more common for prediabetes patients in the future.
